May 23, 2019   SOURCE: PR NewsWire

Dry Powder Inhalers: Key Annual Conference for Pharmaceutical and Medical Device Professionals - London, United Kingdom - June 19-20, 2019

DUBLIN, May 23, 2019 /PRNewswire/ -- The "Dry Powder Inhalers" conference has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Key annual conference for Pharmaceutical and Medical Device Professionals in the DPI market.

The second generation of DPIs have become either established on the market or are a significant way along the approval process. These have been a great success story in improving inhaled drug delivery. However, we now have to tackle the technical and regulatory issues with generic' inhalers and their approval. The development of triple therapies is well underway and these bring about their own challenges of formulation and bioequivalence.

Amazingly, new DPIs are still being created, with some moving in to development programmes. One of the areas where much study and recent guidance has been applied is in considering the patient use, compliance and human factors associated with DPIs. These linked topics are creating a whole new area that requires better understanding during product development and associated studies.

This conference will address many of the issues around generic inhalers, provide case studies of bioequivalence testing, focus on the difficult formulation challenges and the strategies used so that they may be overcome, and discuss in-depth patient and human factor issues when developing a DPI to gain regulatory approval.

Conference programme to include

    --  Current and future challenges for DPI formulations
    --  Novel DPI delivery platforms
    --  Design and characterisation of breath actuation mechanisms
    --  Method for the determination of delivered-dose uniformity and
        aerodynamic particle size distributions of DPIs
    --  Sampling and analysis of inhalation devices in accordance with ISO 18562
    --  Development of a new moisture-resistant DPI which performs well
        irrespective of orientation
    --  How can the physicochemical properties of DPIs and their stability
        impact product performance?
    --  Spray drying of nanopharmaceuticals into microsphere forumulations
    --  INFORM 2020: new analytical insights into dry powder formulations for
        inhalation
    --  Dry powder formulations: from low dosage API delivery to
        biopharmaceuticals
    --  Inhalation products, transitioning from less regulated markets
    --  Challenges with generics
    --  Overcoming the need for comparative clinical endpoint bioequivalence
        studies in a 505(j) ANDA weight of evidence approach for orally inhaled
        products
    --  The 1nhaler and its two jobs
    --  Opportunities and challenges in the design of a high-performance
        unit-dose DPI

Who Should Attend:

Those involved in

    --  Respiratory drug development
    --  Inhalation product development
    --  Device engineering
    --  Formulation development
    --  Scientific research
    --  Medical marketing
    --  Marketing and Business development

Agenda:

Programme - Day one

Current and future challenges for DPI formulations

    --  Today's DPI marketplace
    --  The challenge of formulating new chemical entities (NCEs)
    --  The challenge of developing generic DPIs
    --  Quality by design in DPI formulation

    --  Advanced manufacturing technologyDr David Wyatt

Novel DPI delivery platforms

    --  Marketed DPI platforms
    --  Novel DPI platforms
    --  Capability gaps

    --  Value in the eyes of the consumerPaul Johnson

Design and characterisation of breath actuation mechanisms (BAMs)

    --  Rationale and user requirements for the use of BAMs in inhaled drug
        delivery products
    --  Design considerations for BAMs
    --  Experimental characterisation of BAMs

    --  Comparison of the trigger characteristics in different marketed breath
        actuated inhaler productsJames Tibbatts

Methods for the determination of delivered-dose uniformity and aerodynamic particle size distributions of DPIs

    --  Introduction to inhaled device types and their nuances
    --  Current regulatory requirements for in-vitro testing of DPIs
    --  Delivered dose uniformity testing and APSD measurements by cascade
        impaction

    --  Advances in measurement techniques for bioequivalence testing and
        improving IVIVCsMark Copley

Sampling and analysis of inhalation devices in accordance with ISO 18562

    --  ISO 18562 overview - requirements for respiratory medical devices
    --  Introduction to thermal desorption

    --  Biocompatibility testing using thermal desorption gas chromatographyDr
        Nikhil Sahotra

Development of a new moisture-resistant DPI which performs well irrespective of orientation

    --  Moving from concept to a working prototype - challenges and
        opportunities
    --  Integration of moisture-scavenging technology
    --  Creating a sealed device
    --  Testing challenges

    --  Next steps to a marketed devicePaul Ballington

How can the physicochemical properties of DPIs and their stability impact product performance? A process and delivery perspective

    --  An overview on formulation physicochemical attributes affecting DPI
        processability and delivery performance
    --  Screening of the distinct overtime solid-state, micromeritics and
        surface properties of inhalable particles and de-convolution of their
        impact on product performance

    --  Evaluation of distinct formulation approaches and their potential impact
        on product performanceJoana Pinto

Spray drying of nanopharmaceuticals into microsphere formulations

    --  Nanoparticles as drug carriers
    --  Safety and efficacy, in vitro and in vivo

    --  Respirable dry powder formulationsProfessor Ben Forbes

Programme - Day two

INFORM 2020: new analytical insights into dry powder formulations for inhalation

    --  Structural equivalence for inhaled formulations
    --  Microstructural analytical techniques
    --  Multi-scale computed tomography approaches to look inside formulations

    --  Identifying metrics of relevance to inhaled product performanceProfessor
        Darragh Murnane

Dry powder formulations: from low dosage API delivery to biopharmaceuticals

    --  Drivers for choosing amongst different DPI formulation approaches
    --  Case study on carrier-based DPI formulation development
    --  Case study on spray dried composite DPI formulation development

    --  Capsule filling of challenging DPI powdersEunice Costa

Inhalation products, transitioning from less to more regulated markets, can it be that difficult?

    --  What is less regulated'?
    --  Combination product regulation and how it impacts inhalation products
    --  Regulatory trends, where are things headed?
    --  The typical GAPs and how to try to close them
    --  Is there an easy route?

    --  Is the transition worth it?David Howlett

Formal product characterization studies required for DPI's

    --  Why and when these tests are performed
    --  What to include - how to design an appropriate product characterization
        study
    --  Differences between US and EU requirements

    --  In depth look at the specific tests required (Stability studies,
        Temperature Cycling, Effect of Patient Use, Effect of Orientation, Drug
        Deposition on Mouthpiece, Effect of Varying Flow Rate, Device
        Robustness)Chris Vernall

Overcoming the need for comparative clinical endpoint bioequivalence studies in a 505(j) ANDA weight of evidence approach for orally inhaled products
Dr Rob Price

The Inhaler and its two jobs

    --  The functional, emotional and social reasons that there is a growth
        market for single-dose DPIsDon Smith

Opportunities and challenges in the design of a high-performance unit-dose DPI

    --  Design opportunities and challenges for a fit for purpose' capsule-based
        DPI
    --  Prototyping challenges

    --  Preliminary performance dataAnselm Ebert and George Bostock

For more information about this conference visit https://www.researchandmarkets.com/r/xbdko3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/dry-powder-inhalers-key-annual-conference-for-pharmaceutical-and-medical-device-professionals---london-united-kingdom---june-19-20-2019-300855848.html

SOURCE Research and Markets